Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects

Clinical trial NCT00515203 · COMPLETED

Trial details

NCT number: NCT00515203
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Idiopathic Thrombocytopenic Purpura Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Start date: 2007-07-01
Primary completion: 2009-03-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.